Structure posts early oral obesity data, delays larger readout

Structure posts early oral obesity data, delays larger readout

Structure Therapeutics has shared an early look at the efficacy of its oral GLP-1 receptor agonist, linking the candidate to a 5% reduction in weight after four weeks. | Structure Therapeutics has shared an early look at the efficacy of its oral GLP-1 receptor agonist, linking the candidate to a 5% reduction in weight after four weeks.

Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension

Microorganisms, Free Full-Text

Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models

Intermittent Fasting Improves Memory, Decreases Amyloid Accumulation in Alzheimer's Mouse Model, Aspen Biosciences posted on the topic

Recombinant Human EGF Protein, CF 236-EG-200: R&D Systems

Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies - ScienceDirect

Frontiers The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model

Over the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Study

Stachyose-Enriched α-Galacto-oligosaccharides Regulate Gut Microbiota and Relieve Constipation in Mice

Frontiers Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6